Page last updated: 2024-10-26

etidronate and B-Cell Chronic Lymphocytic Leukemia

etidronate has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research Excerpts

ExcerptRelevanceReference
"Issues relating to the treatment of the osteoporosis as well as the lymphoma arise in patients that present in this way."1.31Lymphoplasmacytoid lymphoma presenting as severe osteoporosis. ( Atoyebi, W; Brown, M; Hatton, C; Littlewood, TJ; Wass, J, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atoyebi, W1
Brown, M1
Wass, J1
Littlewood, TJ1
Hatton, C1

Other Studies

1 other study available for etidronate and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Lymphoplasmacytoid lymphoma presenting as severe osteoporosis.
    American journal of hematology, 2002, Volume: 70, Issue:1

    Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Etidronic Acid; Humans; Leukemia, Lymphocytic, C

2002